CLL Therapy Approaches in Russia

Trial Identifier:	D8220R00038
Sponsor:	AstraZeneca
NCTID::	NCT05140369
Start Date:	October 2021
Primary Completion Date:	October 2025
Study Completion Date:	October 2025
Condition:	CLL (Chronic Lymphocytic Leukemia)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Russia	Irkutsk, Russia
Russia	Moscow, Russia
Russia	Nizhniy Novgorod, Russia
Russia	Novosibirsk, Russia
Russia	Saint Petersburg, Russia

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.